Data Shows Millennials In WA Love Cannabis – But That Doesn’t Mean They’re Big Spenders

Unsurprisingly, cannabis is most popular with Millennials, who grew up in a world with much more liberal views on the plant,” reads the report. Millennials in Washington are snapping up cannabis products more than any other age demographic, according to market data firm Headset. The agency released a report this week on “how much [cannabis] is…

Organigram Positioned for Substantial Growth from Edible Marijuana Products

One of Canada’s leading medical marijuana producers says it is ready to take advantage of the sale of cannabis edibles and concentrates. Organigram Holdings Inc. (TSX-V:OGI) (OTCQB:OGRMF) (the “Company” or “Organigram”) says the recent announcement that the federal government will likely approve the production and sale of edibles for the recreational market will give it…

Efficacy and Tolerability of Phytomedicines in Multiple Sclerosis Patients: A Review

Multiple sclerosis (MS) is a chronic inflammatory and demyelinating disorder of the central nervous system (CNS) that can cause cognition, mobility, and sensory impairments. It is considered one of the most common non-traumatic causes of disability in the world. The aim of the present article was to review the clinical evidence related to medicinal plants in the management of MS symptoms.

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH)

Liver steatosis is common in Human Immunodeficiency Virus (HIV) – Hepatitis C Virus (HCV) co-infected patients. Some recent studies have found that cannabis use is negatively associated with insulin resistance in the general population and in HIV-HCV co-infected patients. Given the causal link between insulin resistance and steatosis, we hypothesised that cannabis use has a positive impact on steatosis.